KelSie Biotech, LLC (“KelSie”) is a Single Purpose Colorado Limited Liability Company headquartered in Boulder, CO. The Company was formed to pursue the research and commercial opportunities contemplated in its Worldwide Licensing Agreement with Colorado Can, LLC (dba Sievers Biotech). This Agreement grants to KelSie, Sievers Biotech’s Technology and Intellectual Property including patent rights related to the commercial development and use of its Bubble Drying Process, Sublingual Wafer, and Dry Powder Inhalable Products. These include but are not limited to the formulation and sale of other finished products, and the right to sublicense said technology and Intellectual Property.
SENIOR MANAGEMENT TEAM
CAMERON F. KELUCHE
President & CEO
Cameron Keluche has provided Economic Modeling, Business Plan Development and Management Services to numerous Technology based enterprises. Prior to founding KelSie, he directed the development and implementation of a proprietary Big-Data Cloud based Platform and Management Information Systems, including Supervisory Controls and Data Acquisition (SCADA) Systems, for the management of natural resources valued in the Billions.
In addition, he has conducted market research and provided analytical, business planning, feasibility impact studies, economic modeling and management services ranging from large scale community developments and environmental assessments to the management of commercial property portfolios valued in excess of $500 Million.
Mr. Keluche is a graduate of the University of Denver with a B.A. Degree in Cognitive Neuroscience with course work in Business Administration at Wake Forest University, and continues his activities in the development and management of new technology based enterprises in the health care industry.
CHRISTIE SIEVERS SPENCER
Ms. Spencer is Vice President and Co-founder of KelSie Biotech. As the daughter of Dr. Robert Sievers, and President of Colorado Can, LLC (dba Sievers Biotech), she has worked with him in the development and operation of the Sievers Biotech Laboratory since 2014. Ms. Spencer has been actively involved guiding Sievers Biotech’s use of its patented Technology and proprietary Intellectual Property for commercial development.
Prior to Sievers Biotech, Ms. Spencer was an area representative for “Always Best Care of Colorado” a franchise with eight senior care facilities in Colorado (2009-2014). From 1990-1993, she was a Program Specialist at the Children’s Hospital. In this position, she coordinated and implemented medical education training programs and conferences as an outreach to medical professionals in the Children’s Hospital’s multi-state referral region.
Ms. Spencer earned a Bachelor of Arts degree in Political Science and Government from the University of Colorado-Boulder. She is an active member of numerous service organizations, including serving as a Board Member of YWCA Boulder County, and a volunteer with the Foundation for Boulder Valley Schools and the Boulder Valley School District.
Chief Operations Officer
Edward Wassom is the COO and Co-Founder of KelSie Biotech. He has extensive experience in developing and managing successful technology-data-based enterprises utilizing advanced data collection, analysis and decision support systems. One of the keys to his success is his skillful use of Enterprise Resource Planning (“ERP”) Solutions, which enables the sharing and integration of many diverse databases that support multiple functions within the enterprise, such as: market research, product development, process control, quality control, sales, distribution, inventory control, customer satisfaction and profit planning and control.
Mr. Wassom most recently managed a diverse multi-product enterprise, improving the company’s overall performance, including expanding its product line from 20 to 84 products, strengthening its brand image and significantly increasing its revenues and profits by managing the production and delivery of this expanded product line on time and within budget.
Mr. Wassom is applying these management skills to assist KelSie and its clients to cost-effectively integrate its proprietary CAN-BD process into their formulation, testing, production and delivery of high quality bioactive products with Active Pharmaceutical Ingredients. With a Management Information Systems degree from Iowa State University, Mr. Wassom is focusing on applying his extensive business development, marketing and management experience to assist KelSie Biotech to commercialize its patented technology and Intellectual Property in a broad range of medical and wellness applications.
Chief Marketing Officer
Steven Addis is a Co-Founder and Chief Marketing Officer of KelSie Biotech. With more than 30 years of branding and marketing experience, Steven brings a wealth of expertise across dozens of product categories. With a passion for brands that motivate positive change, Steven has helped create or revitalize hundreds of brands including Intel, Pepsi, 24 Hour Fitness, Shutterfly, and DuPont. His agency, Addis, flourished as it embraced the shift to digital early in the life of the Internet, focusing on multi-channel brands such as Sephora, Pottery Barn, and Smith & Hawken.
In 2006, the firm doubled down on its positive change ethos and began accepting work only from brands that actively sought to improve the world. Whether it was progress through tech brands or healthy lifestyle food brands, the firm espoused a courageous point-of-view. Work included helping Kashi grow 6x, relaunching thinkThin Protein Bars, revitalizing Nutiva, launching Popchips, and creating brands from the ground-up including Somersaults and Verlasso Salmon. Today, the agency is the branding firm of record for brands like Tejava Iced Tea and indoor farming start-up, Plenty.
A graduate of the University of California-Berkeley, Steven has served 14 years on the board of the Berkeley Art Museum and Pacific Film Archive.
LIA REBITS, PhD
Chief Scientific Officer
Dr. Rebits is a Co-Founder of KelSie Biotech and has an impressive history of translational education and research that encompasses molecular biology, biochemistry, organic chemistry, and analytical chemistry. She worked as a research scientist for Aktiv-Dry, LLC for four years and gained experience with drug delivery, active ingredient stabilization with excipients, optimizing dry powder formulations, and developing analytical methods.
Her post-doctoral work expanded the application of numerous analytical methods and dry powder formulation techniques in the study of plants and extracts. She is co-author with Dr. Sievers on 5 pending patent applications.
In 2014, she graduated with a Ph.D. in Analytical Chemistry from the University of Colorado at Boulder with the thesis, “Expanding the Chemistry of In Vitro Selections Against Extracellular Mycobacterial Glycolipids”, and joined the staff of Sievers Biotech.
Mr. Gildelamadrid is a Co-Founder of KelSie Biotech and prides himself as an engineer with a passion in helping businesses improve and streamline their process and mechatronics equipment.
As a student at the University of Colorado in Boulder, Mr. Gildelamadrid studied International Affairs and Geopolitics, but his passion for physics and engineering quickly inspired him to also pursue a degree in Engineering Physics. He earned undergraduate degrees in both disciplines. Mr. Gildelamadrid started his own research and development business that worked to develop a precise computer controlled methanol injection system that would allow internal combustion engines to increase efficiency.
As the Chief Engineer at KelSie Biotech, he is tasked with optimizing the efficiency, reliability, and productivity of the Company’s patented CAN-BD process and equipment. He has been instrumental in the development of various improvements to the technology and has authored pending patents for these improvements. With his strong understanding of physics fundamentals, he works to broaden the capabilities of the CAN-BD process and make it more user friendly, so it can be used in a multitude of production environments and operated with a limited skill set.
Xuno spent 5 years on active duty for the U.S. Army serving around the globe, from the Korean demilitarized zone to conflict regions in southwest Asia, where he led soldiers in various military operations and received a number of military decorations and awards. After his active duty service, he was recruited to serve as an army instructor. As a reservist, he conducted classroom and field instruction on a variety of war fighting tactics, while continuing his education at the University of Colorado.
Chief Research Officer
Mr. Mathias is a Co-Founder of KelSie Biotech as well as the CRO, and Director of Development of the Company’s education and training materials for care-givers, patients, and academic researchers as well as vetting and exploring patent applications.
He is currently identifying and orchestrating collaborative research opportunities, including but not limited to: PK Studies, Toxicology Studies, Stability Studies as well as engaging in professional and non-profit outreach.
Mr. Mathias graduated Magna Cum Laude with a B.A. in Cognitive Neuroscience from the University of Colorado-Boulder, and worked as a graduate student/research assistant at the CU Integrated Psychology & Neurolinguistics Laboratories. During his academic career, Mr. Mathias remained current with research findings and continues to assist with the production of the Company’s education and training materials.
ROBERT SIEVERS, PhD
Senior Scientific Advisor
Dr. Bob Sievers remains a professor of chemistry and biochemistry at the University of Colorado-Boulder and has distinguished himself as teacher, scientist, department chair, and dean. In 1975, he was recruited by the University of Colorado as a full professor to lead the rebuilding of the Analytical Chemistry Division of the Dept. of Chemistry. CU was interested in the expertise that he brought from his work in the 60’s and 70’s on environmental trace analysis and the analysis of the moon rocks and dust that the astronauts brought back to Earth from the early Apollo Mission. He was also elected a Regent of the University representing Colorado’s 2nd Congressional District and served in that capacity from 1990 to 2002.
Dr. Sievers came to Boulder with the understanding that he would try to create new analytical instruments with unprecedented sensitivity and selectivity, which could lead to a new industry in analytical measurements. His students at CU and he worked diligently, and filed for some patents. In 1984, he and associates founded Sievers Instruments, Inc. and grew it to a staff of 160 by 1996 when it was then acquired by Ionics, Inc. for $21 million in an exchange of stock. More recently, in 2005, GE acquired Ionics for $1.1 Billion.
In 2002 Dr. Sievers, co-founded a new company, AKTIV-DRY LLC, to develop some of the newer inventions described in the 30 US and foreign patents that Sievers and co-workers have been awarded, the most recent of which are aimed primarily of helping prevent disease in developing countries. In 2005, Aktiv-Dry was awarded a $20 million, 5-year Grant by the Foundation for the National Institutes of Health to develop a needle-free measles vaccines system for children in developing countries without electricity or skilled caregivers. This Grant was part of the Grand Challenges in Global Health initiative funded by the Bill and Melinda Gates Foundation, and was administered by the Foundation for the National Institutes of Health. Approximately 400 children die each day from measles related illnesses, primarily in India, Africa, and Asia. The results of the Phase 1 clinical trial conducted by Dr. Sievers were positive.
In 2014, with the passage of section 7606 of the Farm Bill, which made it federally legal in states with Industrial Hemp programs, to study and cultivate Industrial Hemp, he formed Sievers Biotech. On a mission to understand the chemistry of Cannabidiol, an extract from industrial hemp, showing promising potential therapeutic effects in treating the most severe forms of epilepsy, in addition to anxiety disorders, substance use disorders, schizophrenia, cancer, pain, inflammatory diseases and others, Dr. Sievers applied his more than 50 years of expertise in analysis and formulation to develop a dry powder Cannabidiol, that can be administered directly to the lungs.
A Ph.D. graduate of the University of Illinois, Dr. Sievers was a Principal Investigator in the NASA Apollo Lunar Analysis Program. In 1973, he was chosen as a Distinguished Alumnus of the University of Tulsa to recognize his work on the analysis of moon dust, and his studies of atmospheric aerosols. In 2001, he received the Thomas Jefferson Award from the University of Colorado for contributions in science, the arts, and public service.
LINDA SONNTAG, PhD
Dr. Linda Sonntag is a Senior Scientific Advisor and serves on the Board of Directors of KelSie Biotech. She has extensive experience in the research, development, financing and management of many innovative technologies based enterprises in the Life Sciences and Health Care industries. She is also currently serving on the Board of Directors of DeepDyve whose mission is to empower professionals worldwide in scientific, technology and medical research by providing over 30 million articles on-line from thousands of authoritative journals spanning the Life Sciences.
She began her business career as Director of Agricultural and Biotechnology Research for Agrigenetics Incorporated, which was the first firm to genetically engineer new agricultural crops with improved yield, disease and drought resistance, and improved nutritional value. Later in her career, Dr. Sonntag joined the nation’s first stem cell company, SyStemix, Inc. as its President and CEO. Within 6 months of developing a Strategic Plan and reorganizing its research program, SyStemix was credited with discovering the Human Hematopoietic Stem Cell (“HSC”) and patenting their composition of matter.
She earned her Ph.D. in Biochemistry from the University of Witwatersrand in South Africa, and studied at the Weizmann Institute of Science in Israel, and Executive Development programs at the Harvard Business School and MIT’s Sloan School of Management. She performed post-graduate work with Dr. Herb Boyer, the founder of Genentech at UCSF. Dr. Sonntag is a member of many scientific and professional organizations.
Mr. Keluche has extensive experience in the financing, management and direction of technology-based enterprises. He has formed and directed many such enterprises, one of which applied the principals of behavioral science to the design of self-instructional education and training systems (Basic Systems, Inc.); and Agrigenetics, Inc., the nation’s first company which genetically modified plant varieties with improved drought and disease resistance, enhanced nutritional value and higher yields.
He has also formed and managed several enterprises concerned with Natural Resources and the Environment, including one of the first companies to use Digital Globe’s high resolution satellite imagery in the assessment of timber, agricultural and water resources before Google Earth licensed its imagery. He was a director of Radiometrics Inc. which is the nation’s leader in the continuous measurement and monitoring of the thermodynamic energy build-up in the Boundary Layer of the earth’s atmosphere which precedes by several hours the propagation of virtually all catastrophic weather events.
He is a founding Director of the University Corporation for Atmospheric Research Foundation. UCAR is a consortium of over 100 Universities, which manages the National Center for Atmospheric Research (NCAR), a federal laboratory located in Boulder, Colorado.
Mr. Keluche earned a B.S. in Applied Engineering Science from California State University, Chico, and an MBA from the Harvard Business School. He served as a commissioned officer in the U.S. Navy with primary duties as a Naval Aviator; and is a member of numerous professional and service organizations.
CHARLES DEAN CONNOR
Charles Dean Connor has extensive experience in the management and direction of large voluntary health-centric associations, including senior positions with the American Lung Association and the American Red Cross.
Mr. Connor was most recently President and Chief Executive Officer of the American Lung Association National Headquarters in Washington, DC. In this role, he led the nation’s oldest voluntary health association, as it continues to save lives by improving lung health and preventing lung disease. Beginning its second century, the American Lung Association is Fighting For Air through education, advocacy and research.
Prior to being named President and CEO, Mr. Connor served as the Lung Association’s Executive Vice President and Chief Operating Officer. In this position, he oversaw all corporate functions including Development, Advocacy, Policy, Research, Program Services, Communication, Marketing and Field Support.
Before joining the American Lung Association, he was Senior Vice President for Communication & Marketing for the American Red Cross. During his tenure with the Red Cross, he participated in several catastrophic events including Hurricane Katrina, the Tsunami and the overhaul of the organization’s governance structure. In 2005, he was recognized as Public Relations Professional of the Year by the Public Relations Society of America, and in 2005, his department was named PR Team of the Year by PR Week magazine.
Prior to joining the Red Cross, Mr. Connor was Principal for Client Strategy with The Dilenschneider Group in Chicago where he specialized in communications strategy development, litigation support, crisis control, issues management and media relations. Before joining The Dilenschneider Group, Mr. Connor served in Washington, DC as the first director of public affairs for the Federal Judiciary. He built a comprehensive and aggressive national communications program for the federal courts and implemented several innovative programs for the “third branch” of the federal government. Mr. Connor served as the senior advisor to many prominent federal judges around the nation on a wide range of the most sensitive internal matters, including the management of news media interest in high-profile federal court cases.
Before joining the federal judiciary, Mr. Connor served for 25 years as a United States Navy public affairs officer, leaving the service with the rank of Captain. He was the personal communications advisor to the Secretary of the Navy, the CEO of an organization of more than a million employees and $100 billion annual budget. He advised the Secretary on a wide range of national and international communications matters during a period of great organizational change and turmoil due to post-Cold War downsizing and the Tailhook scandal. Prior to this, Mr. Connor served as the COO for the Navy’s global communications program, responsible for planning and coordinating Navy public affairs efforts worldwide.
Mr. Connor also served in London as the senior Navy public relations official in Europe, handling media matters throughout the continent as well as many crises spanning international boundaries. He conceived and managed the Navy’s aspects of the 50th anniversary of D-Day, including the participation by the President and Cabinet, as well as international media coverage of the event. Earlier, Mr. Connor managed communications efforts at U. S. Space Command/NORAD during the Gulf War. Prior to that, he served with the Commander of the United States Third Fleet handling major international crises as well as a successful Alaska public affairs effort that resulted in vital federal legislation. Mr. Connor has also directed national advertising for the Navy’s recruiting program and run the Midwest media relations program for the Navy.
A native of Chicago, Mr. Connor graduated from Loyola University of Chicago Law School and is a member of the bar of both Illinois and the District of Columbia. He holds a B. A. in Political Science from the University of Illinois and attended Portland State University for graduate study in marketing and communications. Mr. Connor is a past member of the board of directors of the American Marketing Association Foundation, the American Judicature Society and the Stars & Stripes newspaper. He has testified before Congressional committees and addressed such distinguished groups as the University of Chicago Graduate School of Business, the Dallas Rotary Club, the Clinton School of Public Service at the University of Arkansas and the Aspen Institute.